Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Harbour BioMed Announces Global Out-License Agreement with AstraZeneca for CLDN18.2xCD3 Bispecific Antibody HBM7022 2022-04-07 09:09
ENSEM Therapeutics, a CBC Group-Incubated Biopharma Company, Raises $67 Million in Series A Financing to Develop Small Molecule Medicines for Difficult-to-Drug Targets 2022-04-07 04:00
Pregene Enters into Innovative Partnership with CellPoint to Develop anti-BCMA CAR-T Cell Therapy in Europe and the US 2022-04-06 20:30
Antengene's Pivotal "MARCH" Study to Evaluate Selinexor (ATG-010) in Relapsed or Refractory Multiple Myeloma Published in BMC Medicine 2022-04-06 20:03
Ceres Nanosciences Establishes Sixteen Wastewater-Based Epidemiology Centers of Excellence Under NIH RADx Initiative 2022-04-06 19:37
Digital Engagement Continues to Soar Amongst Biopharmas in APAC 2022-04-06 05:00
Singlera Genomics announces research collaboration with Astellas Pharma pursuing methylation-based tools to better understand biological reactions to pharmaceuticals 2022-04-05 21:56
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer's in the EU and UK 2022-04-05 14:00
Sirnaomics Doses First Subject in Phase I Clinical Trial of STP707 for the Treatment of Liver Fibrosis in Primary Sclerosing Cholangitis 2022-04-04 21:31
Vieworks to Make Its Debut at AACR Annual Meeting 2022 with VISQUE InVivo Series 2022-04-04 21:00
Ascletis Announces Completion of First Sale of Its Ritonavir Tablets in Zhejiang Province 2022-04-04 17:10
SeaX Ventures Launches $60 Million Fund II to Help International Startups Expand in Southeast Asia 2022-04-04 16:00
B.I.G. VISION® FOR ALL from Rodenstock: Optimal vision with biometric lenses for everyone 2022-04-04 15:48
CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China 2022-04-04 08:30
Innovent Releases Results of a Phase 3 Clinical Study of IBI306 (PCSK-9 inhibitor) in Chinese Patients with Heterozygous Familial Hypercholesterolemia at the American College of Cardiology Annual Congress 2022 2022-04-04 08:00
Commercial Launch: Illuccix® Now Available to Order in the United States 2022-04-04 07:06
Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting 2022-04-01 23:45
Zhongze Therapeutics Announces Successful Completion Of The First-In-Human Dose Escalation Study of ZZ6398 in Healthy Volunteers 2022-04-01 16:55
Zhimeng Biopharma Announces Dosing of First Subject in First-in-Human Phase -- Clinical Trial of CB06 2022-03-31 23:40
I-Mab Announces Voluntary Lock-ups by Key Shareholders and Senior Management for Long-Term Commitment 2022-03-31 20:00
1 183 184 185 186 187 452